ACTIVE_NOT_RECRUITING

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this pilot study is to evaluate the impact of All4Cure enrollment on patients with multiple myeloma. The main question it aims to answer are: • Does All4Cure effect patient activation as assessed by the PAM-13 survey? Participants will be asked to: * fill out quarterly PAM-13 surveys through the All4Cure website to assess patient activation. * fill out monthly Patient Reported Outcome (PRO) surveys through the All4Cure website. * fill out a baseline and exit All4Cure surveys through the All4Cure website to assess patient perceptions of All4Cure at the beginning and the end of the study.

Official Title

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Quick Facts

Study Start:2023-03-01
Study Completion:2026-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05673083

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. have a diagnosis of multiple myeloma.
  2. 2. are aged 18 years and older.
  3. 3. can read and e-consent to participate in the study.
  4. 4. can speak English.
  5. 5. can complete surveys at pre-specified intervals.
  6. 6. have access to a device that would allow for the completion of surveys (including at home, at work, at the oncologist's office or elsewhere).
  7. 7. are cared for by a physician who is enrolled in All4Cure.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Locations (Sites)

Highlands Oncology Group
Fayetteville, Arkansas, 72703
United States
Cancer Specialists of North Florida
Jacksonville, Florida, 32003
United States
Misson Cancer + Blood
Des Moines, Iowa, 50314
United States
Hematology-Oncology Associates of Central New York
East Syracuse, New York, 13057
United States
Oklahoma Cancer Specialists and Research Institute
Tulsa, Oklahoma, 74146
United States
Oncology Consultants
Houston, Texas, 77030
United States
Northwest Medical Specialties PLLC
Tacoma, Washington, 98405
United States

Collaborators and Investigators

Sponsor: All4Cure

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-03-01
Study Completion Date2026-03

Study Record Updates

Study Start Date2023-03-01
Study Completion Date2026-03

Terms related to this study

Keywords Provided by Researchers

  • Multiple Myeloma
  • All4Cure
  • Patient Activation
  • PAM-13

Additional Relevant MeSH Terms

  • Multiple Myeloma in Relapse
  • Multiple Myeloma
  • Multiple Myeloma, Refractory
  • Multiple Myeloma With Failed Remission